abstract: Previously we showed that extravillous cytotrophoblast (EVT) outgrowth and migration on a collagen gel explant model were affected by exposure to decidual natural killer cells (dNK). This study investigates the molecular causes behind this phenomenon. Genome wide DNA methylation of exposed and unexposed EVT was assessed using the Illumina Infinium HumanMethylation450 BeadChip array (450 K array). We identified 444 differentially methylated CpG loci in dNK-treated EVT compared with medium control (P , 0.05). The genes associated with these loci had critical biological roles in cellular development, cellular growth and proliferation, cell signaling, cellular assembly and organization by Ingenuity Pathway Analysis (IPA). Furthermore, 23 mobility-related genes were identified by IPA from dNK-treated EVT. Among these genes, CLDN4 (encoding claudin-4) and FUT4 (encoding fucosyltransferase IV) were chosen for follow-up studies because of their biological relevance from research on tumor cells. The results showed that the mRNA and protein expressions of both CLDN4 and FUT4 in dNKtreated EVT were significantly reduced compared with control (P , 0.01 for both CLDN4 and FUT4 mRNA expression; P , 0.001 for CLDN4 and P , 0.01 for FUT4 protein expression), and were inversely correlated with DNA methylation. Knocking down CLDN4 and FUT4 by small interfering RNA reduced trophoblast invasion, possibly through the altered matrix metalloproteinase (MMP)-2 and/or MMP-9 expression and activity. Taken together, dNK alter EVT mobility at least partially in association with an alteration of DNA methylation profile. Hypermethylation of CLDN4 and FUT4 reduces protein expression. CLDN4 and FUT4 are representative genes that participate in modulating trophoblast mobility.
Introduction
Cytotrophoblasts display strong mobility and invasiveness while differentiating into extravillous trophoblasts (EVT) during implantation and placentation. EVT penetrate the decidua and the inner third of the myometrium where they replace endothelial cells to remodel spiral arteries. This process is regulated by maternal immune cells, growth factors, extracellular matrix components and adhesion molecules at the fetal-maternal interface (Damsky et al., 1992; Knofler, 2010; Wallace et al., 2012) . The functional change in EVT is accompanied by the alteration of gene expression (Burrows et al, 1996; Fukushima et al., 2005) . The gene expression alteration in EVT may be associated with epigenetic modification, as well as transcriptional, post-transcriptional and translational regulation.
Immune cells and the maternal -fetal interface play an important role in the regulation of implantation and placentation. A subset of natural killer cells (NK) expressing CD56 bright /CD16 2 are the dominant immune cells in the decidua during the first trimester of pregnancy, and interact directly with EVT. The decidual NK (dNK) cells exert lower cytotoxic but higher secretory capacity compared with peripheral NK cells (Hanna et al., 2006; Yagel, 2009; Wallace et al., 2012) . Evidence from our own and other studies demonstrates that dNK regulate EVT migration and invasion through secreted soluble growth factors such as transforming growth factor-beta (TGF-b1 and TGF-b2) (Clark et al., 1994; Karmakar and Das, 2002; Lash et al., 2006) ; chemokines such as interleukin (IL)-8 and interferon gamma inducible protein-10 (IP-10) (Hanna et al., 2006) ; and cytokines such as IL-6, IL-10, interferon (IFN)-g and tumor necrosis factor (TNF)-a (Vigano et al., 2001; Hu et al., 2006 Hu et al., , 2008 Eastabrook et al., 2008; Pitman et al., 2013) . Among these factors, TGF-b1, TGF-b2, IL-10, IFN-g and TNF-a potentially restrict EVT migration and invasion (Clark et al., 1994; Lash et al., 2005; Hu et al., 2006 Hu et al., , 2008 Pang et al., 2008) ; while other factors like IL-8 and IP-10 were reported to promote EVT migration and invasion (Hanna et al., 2006) . What has not yet been shown is the mechanisms by which the behavior of EVT is altered upon interacting with dNK. DNA methylation is an epigenetic modification which plays a role in programmed gene regulation during cellular differentiation as well as adaptation to environmental conditions. DNA methylation occurs almost exclusively at CpG dinucleotides, and is commonly associated with altered gene expression (Mohtat and Susztak, 2010; Hamilton, 2011) . Widespread changes in DNA methylation are found in placentas associated with pregnancy complications such as pre-eclampsia (Yuen et al., 2010; Blair et al., 2013) . Alterations in DNA methylation have also been observed in cytotrophoblasts exposed to varying oxygen tensions .
Our previous study investigated the interaction of dNK and EVT cells using an ex-vivo first trimester villous explant culture on collagen gel (Hu et al., 2006) . We found that EVT underwent outgrowth, column formation and then migration from the anchoring villous tips when cultured alone or with IL-15 (used to support dNK proliferation and survival). By co-culturing explants with either dNK directly or dNK trapped inside a hollow fiber (HF-dNK), the EVT outgrowth pattern was altered and EVT migration appeared to be restricted by both dNK and HF-dNK. The phenotypic changes in EVT were associated with changes in protein expression, including matrix metalloproteases-2 and -9 (MMP-2 and MMP-9) and plasminogen activator inhibitor-1.
In the current study, we examined whether or not dNK-induced EVT phenotypic alterations were associated with changes of DNA methylation. Whole genome DNA methylation was surveyed using the Infinium HumanMethylation450 BeadChip array (450 K array). The network composition and bio-functional analysis by ingenuity pathway analysis (IPA) software identified molecular pathways and gene sets associated with cellular development, growth and proliferation, signaling, organization and maintenance, and notably, with cellular movement. We hypothesized that the methylation alteration of cellular movement genes by dNK might influence gene expression, leading to the changes of cellular behaviors including migration and invasion, the phenomenon we observed previously (Hu et al., 2006) . Hence, the confirmation of methylation, gene expression analysis and gene functional assessment were focused on two candidate genes [CLDN4 (encoding Claudin-4 protein or CLDN4) and FUT4 (encoding Fucosyltransferase IV protein or FUT4)] from an IPA identified gene set associated with cellular movement.
Materials and Methods
Preparation of dNK, HF-dNK and first-trimester villous explant culture Placental tissues were collected from healthy women undergoing elective pregnancy termination at gestational ages of 7 -9 weeks with ethical approval from the University of British Columbia and BC Children's and Women's Hospital ethics boards. Written informed consent was obtained from all women. dNK isolation, HF-dNK preparation and placental villous explant culture in rat-tail collagen were described previously (Hu et al., 2006 . In brief, dNK were isolated from decidua after collagenase and hyaluronidase digestion and depletion of attached cells. They were then enriched using a human NK cell enrichment cocktail following the manufacturer's instructions (StemCell Technologies, Inc., Vancouver, Canada). The percentage of CD56 + /CD16 2 dNK reached 87%, while CD16 + cells were ,2.1% (Hu et al., 2006) . The dNK were trapped inside a hollow fiber (Spectrum Laboratories, Inc., Rancho Dominquez, CA, USA) (HF-dNK) and used for co-culturing with explants in order to eliminate trophoblast cell contamination from dNK when performing EVT DNA extraction. The HF permits soluble factors with molecular weight below 500 kDa to be exchanged freely. For each placental specimen, villous explant cultures were set up in 12 well plates on collagen gel. After overnight incubation, explant cultures were exposed to medium control (Dulbecco's modified Eagle's medium/ F12 supplemented with 10% fetal bovine serum (FBS)), or medium plus IL-15, or concordant HF-dNK plus IL-15, for a total of 96 h. In the whole study 'HF-dNK' refers to HF-dNK plus IL-15. We used 6 -8 explants for each treatment group in each placental specimen. During the incubation, EVT moved out from the villous tips and expanded over the collagen gel. They migrated in a radially oriented direction especially from the edge of the column in the presence of medium control or medium plus IL-15, or were highly packed, especially around the edge of the column in the presence of HF-dNK (Hu et al., 2006) .
DNA extraction of EVT from explant cultures
For each of the explant cultures, EVT were harvested from collagen gel after dissecting out villous tissue and pooled for each treatment group. Previous work has shown that the EVT harvested from collagen gel were cytokeratin positive and vimentin negative cells and purity was high (Hu et al., 2006 . Genomic DNA from EVT was purified using the QIAamp DNA mini kit according to the manufacturer's instructions (Qiagen, Inc., Mississauga, ON, Canada). Five placental specimens in total were used for the global DNA methylation array and Bisulfite pyrosequencing validation.
Illumina HumanMethylation450 array
DNA samples were run on the Illumina HumanMethylation450 BeadChip (Illumina, Inc., San Diego, CA, USA) (450 K array) as described Yuen et al., 2013) . This array quantifies methylation at .480 000 cytosine-guanine dinucleotide (CpG) sites in 99% of RefSeq genes. Briefly, 750 ng of DNA was bisulfite converted using EZ DNA Methylation Kit (Zymo Research, Irvine, CA, USA). Hybridization of samples was performed following the manufacturer's protocol. Each chip was scanned by a HiScan 2000 (Illumina). Raw data were extracted into GenomeStudio (Illumina) and was subject to (i) background subtraction; and (ii) elimination of probes with detection P-value .0.01. In R, measurements were converted to an M-value (log 2 ratio of the intensities of methylated to unmethylated probes), color channel corrected and normalized using sub-quantile within array normalization. Candidate sites were prioritized by (i) P-value ,0.05 and (ii) the magnitude of mean difference .10% (i.e. Db > 0.10) between control group and sample group. Raw and processed data were deposited into the public database GEO (ncbi.nlm.nih.gov/geo/; GSE60885).
DNA methylation confirmation by bisulfite pyrosequencing DNA methylation of selected candidate genes CLDN4 and FUT4 was confirmed using bisulfite pyrosequencing as described . Assays were designed using PSQ Assay design (Biotage, Upsalsa, Sweden). Gene network and pathway analysis IPA (Ingenuity Systems, Redwood City, CA, USA) was used to carry out analyses for network composition and molecular and cellular functions for differentially methylated CpGs across various gene regions in HF-dNK-treated EVT cells. Each gene symbol was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. Networks of these genes were algorithmically generated based on their connectivity and assigned a score. The score is a numerical value used to rank networks according to how relevant they are to the genes in the input dataset but may not be an indication of the quality or significance of the network. The network identified is then presented as a graph indicating the molecular relationships between genes/gene products. The over-represented cellular and molecular functions were ranked according to the calculated P-value.
Flow cytometer
We performed cytometric analysis (FACScan flow cytometer, Beckton Dickinson, Oakville, ON, Canada) for CLDN4 and FUT4 protein expression level in EVT harvested from villous explants as described (Hu et al., 2006 . The data were generated from five placental specimens. In brief, villi were dissected from explant cultures, EVT were collected from collagen gel after treating with 0.25% EDTA and pooled from each treatment group. EVT were then fixed by adding 37% formaldehyde solution directly into cell suspension to obtain a final concentration of 1.5% formaldehyde. Cells were incubated for 20 min and pellets were collected by centrifugation at 300g for 5 min. Cells were then permeabilized by 100% ice-cold methanol for 5 min. Following permeabilization, cells were stained with Alexa Fluor 488-conjugated mouse anti-Claudin4 (Clone 3E2C1, Invitrogen, Frederick, MD 21704, USA) or rabbit anti-human FUT4 (sc-292247, Santa Cruz Biotechnology, Inc., Santa Cruz, CA 95060, USA) followed by fluorescein isothiocyanate labeled goat anti-rabbit immunoglobulin (Ig).
Total RNA preparation, first-strand cDNA synthesis and qPCR
Villi were removed from each explant culture. EVT were lysed and pooled from the same assay group and total RNA was prepared using RNeasy plus Mini kit according to the manufacturer's protocol (Qiagen, Inc., Mississauga, ON, Canada) as described previously (Hu et al., 2006) . Additionally, total RNA was prepared from HTR8/SVneo cells for CLDN4 siRNA and FUT4 small interfering (si)RNA knocking down efficiency test. The cDNA synthesis was performed using SuperScript III first-strand Synthesis SuperMix kit (Invitrogen, Burlington, ON, Canada) and quantitative PCR (qPCR) was performed in an ABI prism 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). After 2 min at 508C and 10 min at 958C the samples were cycled 40 times at 958C for 15 s and 608C for 60 s. The relative quantification of gene expression was calculated using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-actin (ACTB) gene expression as endogenous controls, as described (Hu et al., 2006) and presented as relative expression in EVT in treated groups compared with medium control group. Knockdown of CLDN4 and FUT4 by siRNA in HTR8/SVneo, immunocytochemistry staining and western blot
The X-tremeGENE siRNA transfection reagent (Roche, Basel, Switzerland) was used for siRNA transfection (Eastabrook et al., 2012) . Human siGEN-OME CLDN4 siRNA SMARTpool, ON-TARGET plus FUT4 smart pool siRNA and non-targeting control siRNA were purchased from Dharmacon, Thermo Fisher Scientific Biosciences (Lafayette, CO, USA). After transfection efficiency optimization, HTR8/SVneo cells were transfected with 50 nM, 12 nM and 3 nM CLDN4 siRNA, FUT4 siRNA or control siRNA. The co-transfection of CLDN4 and FUT4 at 3 concentrations was also carried out. At 72 -96 h after transfection, the CLDN4 and FUT4 siRNA single and/or co-transfected cells were used for immunocytochemistry staining, western blot and/or invasion assay.
Immunocytochemistry staining: CLDN4, FUT4 and control siRNA transfected HTR8/SVneo cells were seeded on cover slips. After overnight incubation, cells were fixed with ice-cold methanol, then blocked with phosphate-buffered saline (PBS) supplemented with 10% FBS and exposed to primary rabbit polyclonal anti-CLDN4 (sc-17664-R, Santa Cruz Biotechnology) or rabbit polyclonal anti-Fut4 antibody (sc-292247) at 2 mg/ml concentration overnight at 48C. Cells were washed before exposing to Alexa Fluor 594-conjugated goat anti-rabbit IgG antibody (Life technology). The cover slips were mounted with Prolong gold antifade reagent with 4 ′ ,6-Diamidino-2-phenylindole (DAPI, Life technology).
Western Blot: The siRNA transfected HTR8/SVneo cells were lysed and underwent the procedures for western blot as described previously (Hu et al., 2010) . The primary rabbit polyclonal anti-CLDN4 (sc-17664-R, Santa Cruz Biotechnology) and rabbit polyclonal anti-Fut4 antibody (sc-292247) were used for the detection of CLDN4 and FUT4 protein expression.
Invasion assay
HTR8/SVneo invasion assays were performed in 24 well format 8 mm transwell inserts with polyethylene terephthalate track-etched membranes (Becton Dickinson, Franklin Lakes, NJ, USA) (Hu et al., 2010) . The inserts were coated with growth factor reduced Matrigel (BD Biosciences, Bedford, MA 01730, USA). Briefly, CLDN4, FUT4 and control siRNA transfected cells were harvested and washed with PBS. Cells (2 × 10 5 ) in 0.1% FBS containing RPMI1640 media were loaded onto the top of the inserts. RPMI1640 containing 10% FBS was added to the bottom of the inserts. After overnight incubation, the inserts were transferred to new plates that contained 225 ml of a 0.25% trypsin solution. The plate was incubated with shaking for 20 min. The inserts were then discarded and cells were stained with DNA dye CyQuant solution in lysis buffer (Molecular Probes, Invitrogen) for 20 min. Following that, 200 ml of cell mixture from a 24 well plate were transferred into a 96 well plate and the fluorescence was read with a fluorescent plate reader at 480 nm excitation and 520 nm emission. The results were expressed as % of control [% of control ¼ (relative fluorescence units (RFU) in assay group -background) * 100/(RFU in control siRNA group -background)]. Each assay was repeated for a total of four times.
Total and active MMP-2 and MMP-9 activity assessment
Following CLDN4 and FUT4 siRNA knock down in HTR8/SVneo cells, the supernatants were collected at 72 h and used for total and active MMP-2 and MMP-9 activity measurement using MMP-2 and MMP-9 Biotrak Activity Assay System (GE Healthcare, Amersham Place, Little Chalfont, Buckinghamshire, UK) (Hu et al., 2006) . The results were presented as % of control [% of control ¼ (MMP level in assay siRNA group-background) *100/(MMP level in control siRNA group-background). Each assay was repeated for a total of five times.
Statistics
Data are presented as mean + SD. Groups were compared with analysis of variance (ANOVA). When ANOVA showed a significant difference for the groups (P , 0.05), then post test was performed with Bonferroni comparison or Dunn's multiple comparison, as appropriate, using GraphPad Prism 4.0 software (San Diego, CA, USA). For the 450 k array, statistical significance was determined using Student's T-test with P-value cut-off set at P , 0.05.
Results

Genome-wide DNA methylation of explant culture-derived EVT
The 450 k array was used to evaluate genome-wide DNA methylation of EVT exposed to medium control, IL-15, and HF-dNK. Each group included five different placental specimens. To determine visually the relationship of samples with each other, two dimensional principal component analyses was used ( Supplementary Fig. S1 ). As expected, samples clustered by the placenta of origin rather than by treatment, suggesting that genetic effects on the DNA methylome were the main source of variance among samples. 
DNA methylation of extravillous cytotrophoblast
Alteration of EVT DNA methylation by exposing to HF-dNK
No loci were significant using a false discovery rate (FDR) analysis which corrects for multiple comparisons. However, using a cut-off of P , 0.05 and .10% absolute average methylation difference (Db . 0.1 from 450 k array) before and after treatment, we identified 73 (24 hypermethylated; 49 hypomethylated) and 444 (376 hypermethylated; 68 hypomethylated) candidate methylation changes in IL-15 and HF-dNK-treated EVT, respectively, compared with medium control. Hence the NK treatment appeared to have a greater effect on EVT DNA methylation than the IL-15 treatment. Of the 73 loci altered with IL-15 treatment, 5 CpGs (representing 5 genes) were in common with those altered in HF-dNK-treated (0.09%) EVT, indicating that there may be a minimal overlap in effect (Fig. 1) . Subsequent analysis was focused on candidates derived from HF-dNK-treated EVT. The genomic sequence from 200 bp downstream to 200 bp upstream surrounding each significant CpG from HF-dNK-treated EVT was interrogated for recurring DNA motifs and none were found to be significant.
IPA of DNA methylation changes
To identify pathways and functional groups enriched by differentially methylated loci in HF-dNK-treated EVT, the 444 CpG loci with altered Figure 2 The two representative networks by ingenuity pathway analysis (IPA) for differentially methylated whole gene set derived from HF-dNK-treated EVT. (a) Extracellular signal-regulated protein kinase 1 and 2 (Erk1/2) was centered in one of the top network pathways, and Claudin-4 (CLDN4) was revolved this pathway. (b) Protein kinase B (AKT) was centered in another top network pathway, and fucosyltransferase IV (FUT4) was revolved this pathway. The analyses indicate that the differentially methylated genes from HF-dNK-treated EVT are located in pathways related to cellular development, cellular function and maintenance, and cell-to-cell signaling and interaction, revolving around key cellular proteins AKT and Erk1/2. The color intensity of node indicates the degree of hyper-or hypo-methylation. Genes encoding for molecules in red are hypermethylated while those in green are hypomethylated relative to control EVT. The shape of each node denotes the molecule class displayed beside each figure. The nodal relationships indicated in solid lines denote direct while those in dashed lines denote indirect interactions. AGAP2: ArfGAP with GTPase domain, ankyrin repeat and PH domain 2; ARC: Activity-regulated cytoskeleton-associated protein; BCL3: B cell lymphoma 3 protein; BMP4: bone morphogenetic protein 4; CD3: cluster of differentiation 3; CD44: cluster of differentiation 44; CLIC3: chloride intracellular channel 3; CNTN1: contactin 1; CNTNAP1: contactin associated protein 1; DEF6: differentially expressed in FDCP 6 homolog; DNER: delta and notch-like epidermal growth factor-related receptor; FGFR3: fibroblast growth factor receptor 3; GPC1: glypican 1; HEYL: hes-related family bHLH transcription factor with YRPW motif-like; Hsp90: 90 kDa heat shock protein; IL4I1: interleukin 4 induced 1; ITGB7: intergrin, beta 7; JAK: janus kinase; JAK3: janus kinase 3; KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6; KLK7: kallikrein-related peptidase 7; LNPEP: leucyl/cystinyl aminopeptidase; LRP1B: low density lipoprotein receptorrelated protein 1B; MAP6: microtubule-associated protein 6; MAPK: mitogen-activated protein kinase; MPL: myeloproliferative leukemia virus oncogene; NEUROD1: neuronal differentiation 1; NOTCH3: Notch homolog 3; PDGF BB: platelet-derived growth factor beta polypeptide homodimer; PELI2: pellino E3 ubiquitin protein ligase family member 2; PIP5K1C: phosphatidylinositol-4-phosphate 5-kinase, type I, gamma; PITX1: paired-like homeodomain 1; PLCB2: phospholipase C, beta 2; PTCRA: pre T-cell antigen receptor alpha; RASAL1: RAS protein activator like 1; ROCK: rho-associated, coiled-coil-containing protein kinase; S100A16: S100 calcium binding protein A16 methylation across gene regions were entered into the IPA software. Among them, 324 CpG sites across 275 individual genes were mapped to the IPA database and underwent core analysis. The top 5 associated network functions and top 5 molecular and cellular functions that were over-represented in the data set, along with the number of genes assigned to each category, are listed in Table I . The network composition and top four networks were centered on key cellular proteins p38 mitogen-activated protein kinase (P38 MAPK), phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) and extracellular signalregulated protein kinase 1 and 2 (ERK1/2), and hence were involved in critical cellular functions of cell-to-cell signaling and interaction, cell proliferation and cell mobility. Two representative networks out of the top 5 are shown in Fig. 2 . The primary molecular and cellular functions of genes derived from HF-dNK-treated EVT were associated with cellular development, cellular growth and proliferation, cell signaling and interaction, and especially with cellular movement, which is in line with our previous finding that HF-dNK regulate EVT migration and invasion (Hu et al., 2006) . Exposure of HF-dNK to EVT resulted in DNA methylation alteration of 23 cell mobility genes (Table II) . Of these genes, 19 were associated with hypermethylated CpGs and the remainder were associated with hypomethylated CpGs. The top 50 differentially hypermethylated CpGs and all hypomethylated CpGs which mapped to the IPA database and were associated with non-mobility genes by IPA are listed in Supplementary Tables SI and SII, respectively. The genes assigned to the categories with other molecular and cellular functions are listed in Supplementary Table SIII. mRNA expression profile for a subset of mobility-related genes and follow-up of the CLDN4 and FUT4 methylation changes with bisulfite pyrosequencing
The mRNA expression profile of EVT from explants was carried out for a subset of genes from the mobility list (Table II) and normalized by GAPDH (Table III) . The house-keeping gene ACTB confirmed the results obtained by normalizing data with GAPDH (data not shown).
The differentially hypermethylated CpGs for BMP4, FGFR3, JAK3, ITGB7, PRKAR1B, PIP5K1C and TRIP6 were located in the gene-body, and their mRNA expression levels were decreased for BMP4, FGFR3, PRKARIB and TRIP6, increased for JAK3 and ITGB7 or did not reach statistical significance for PIP5K1C. The hypomethylated CpG for IL-18 was in transcription start site (TSS) 200, and its mRNA expression showed a trend of increased expression but did not reach statistical significance. The hypermethylated CpGs for CLDN4 and FUT4 were in the first exon which overlapped with a putative enhancer (Fig. 3) and their mRNA expression levels were reduced (Table III ).
In the subset of genes, two significant sites were identified for followup study due to their association with functionally relevant genes. CLDN4 is a member of a large family of transmembrane proteins that are essential in the formation and maintenance of tight junctions. Claudins influence a wide variety of processes including cell signaling, proliferation, differentiation, trafficking and polarity (Escudero-Esparza et al., 2011) . FUT4 is a member of a family of genes involved in various biological processes, including cell adhesion, lymphocyte homing, embryo-fetal development, tumor progression, etc. (Cailleau-Thomas et al., 2000; Julien et al., 2011; Padro et al., 2011; Yang et al., 2013) . Pyrosequencing results confirmed an increase in DNA methylation at each candidate CpG and adjacent CpGs for HF-dNK-treated EVT, but not IL-15, for CLDN4 and FUT4 (Supplementary Fig. S2 ). EVT harvested from villous explant cultures had decreased CLDN4 and FUT4 protein expression as measured by flow cytometry (Fig. 4a and b) as well as decreased mRNA expression as detected by RT-qPCR (Table III) . These data indicate that CLDN4 and FUT4 expression is inversely correlated with DNA methylation at the exon 1 enhancers. To determine the role of CLDN4 and FUT4 in EVT, siRNA was introduced into the EVT cell line, HTR8/SVneo, to knock down their expression level. Knockdown efficiency was confirmed by RT-qPCR. At 48 h after transfection, CLDN4 and FUT4 siRNA, but not control siRNA, at concentrations as low as 12 nM showed .70% CLDN4 mRNA and FUT4 mRNA reduction as detected by RT-qPCR which was normalized by GAPDH (Fig. 5a ) and ACTB (data not shown). CLDN4 and FUT4 protein expression was reduced 72 -96 h after transfection, as detected by western blot (Fig. 5b) and immunocytochemistry staining (Fig. 5c) . The CLDN4 antibody stained a primary membrane protein and FUT4 antibody stained a primary cytoplasmic protein in HTR8/SVneo cells (Fig. 5c) . Knockdown of CLDN4 and FUT4 was accompanied by a reduction of HTR8/SVneo invasion (Fig. 6) . Co-transfection with CLDN4 siRNA and FUT4 siRNA can knockdown CLDN4 and FUT4 mRNA expression as effectively as CLDN4 siRNA or FUT4 siRNA transfection alone. However a further reduction of invasion compared with CLDN4 or FUT4 transfection alone was not observed (data not shown). Active MMP-2 and MMP-9 as well as total MMP-2 and MMP-9 were reduced following CLDN4 knocking down (Fig. 7a and b) . In the case of FUT4 knockdown, active MMP-2 and total MMP-2 changes did not reach significance (Fig. 7c) ; active MMP-9 was reduced while total MMP-9 was increased (Fig. 7d) .
Discussion
In this study, we observed alterations of DNA methylation in EVT exposed to dNK using a large-scale microarray approach and, for two selected genes, demonstrated corresponding changes in mRNA and protein expression. Through secreted soluble factors, such as growth factors, chemokines and cytokines (Clark et al., 1994; Vigano et al., 2001; Hanna et al., 2006; Hu et al., 2006 Hu et al., , 2008 Lash et al., 2006; Pitman et al., 2013) , dNK regulate EVT phenotypic traits, such as cell invasion, by affecting protein expression; this altered expression can be associated with altered DNA methylation (Fig. 1) . Using the 450 k array, we observed no global DNA methylation level change by HF-dNK treatment compared with medium control; however we did see a small percentage of CpG loci which were altered with HF-dNK exposure (Fig. 1) . Many of these loci were located on genes which are in critical cell signaling pathways such as p38 MAPK, PI3K/AKT and ERK1/2 pathways. CLDN4 and FUT4, the two follow-up genes in the current study, were involved in ERK1/2 and AKT pathways ( Fig. 2a and b) . The results indicate how dNK may modulate EVT functions. IL-15 was applied in HF-dNK when co-culturing with explants to maintain dNK viability and proliferation. There were 73 CpG loci methylation alterations using our cut-off in IL-15-treated EVT. Among them, there were only 5 loci in common with HF-dNK-treated EVT, indicating the minimal impact of IL-15 on EVT DNA methylation by HF-dNK.
Changes in DNA methylation can cause changes in gene expression or changes in gene expression can drive changes in DNA methylation. While we can only speculate about the mechanism, as invasive EVT in decidua are non-dividing cells hence changes to DNA methylation must be replication-independent. DNA methylation is accomplished and maintained by a family of enzymes called DNA methyltransferases (DNMTs). DNMTs can be regulated by steroid hormones, growth factors, cell cycle regulators, viruses and cytokines (Logan et al., 2013) . dNK produce a number of soluble factors which can potentially modulate DNMTs expression, leading to EVT DNA methylation alteration. IL-6 was reported to increase DNMT1 expression and epigenetically regulate the expression of several genes in cholangiocarcinoma (Braconi et al., 2010) ; TGF-b1 modulated DNMTs expression and TGF-b signaling is directly and indirectly related to all DNA methylated genes detected in prostate cancer Lee et al., 2012) ; TNF-a reduced DNA methylation in chondrocytes via inhibiting DNMT1 expression (Hashimoto et al., 2009) . While active DNA methylation may result from DNMT expression and activity changes, some changes to DNA methylation may also occur as a consequence of chromatin changes resulting from protein binding associated with gene expression.
The DNA methylation profiling of EVT interacting with HF-dNK identified a list of EVT mobility-related genes (Table II ). The roles of some genes from the list has been studied in oncology but not yet explored in trophoblast biology, as is the case for CLDN4 and FUT4 investigated in the current study. Other examples include CD44, BMP4, TRIP6 and phospholipase C, beta 2 (PCLB2) (Bertagnolo et al., 2007; Guo et al., 2012; Idowu et al., 2012; Grunewald et al., 2013) , and a few kinases such as mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1), mitogen-activated protein kinase 10 (MAPK10), PIP5K1C and FGFR3 which are located in MAP kinase, phosphoinositide and FGFR cell signaling pathways involving in cell proliferation, migration and invasion. The result here implies that multiple cell mobility regulatory genes may be involved in dNK-mediated EVT migration and invasion modulation.
The relationship between DNA methylation and expression is complex and related in part to the genomic location of the methylated elements. DNA methylation in the promoter region is often associated with down-regulation of gene expression (Wong et al., 2010) . DNA methylation in the first exon may also be linked to transcriptional silence (Brenet et al., 2011) . In contrast, gene-body DNA methylation tends to be positively correlated with gene expression levels (Rauch et al., 2009) . A recent study has shown that the relationship between gene-body DNA methylation and expression level is non-monotonic and bell-shaped (Jjingo et al., 2012) . The mRNA expression level of individual genes observed in Table III was not always correlated with DNA methylation level. There is however not expected to be a one-to-one correspondence with gene expression and many other factors may be relevant for regulating gene expression. For example, EVT gene expression may be regulated by DNA-binding transcription factors, or stimulated by dNK-secreted growth factors, chemokines and cytokines (Clark et al., 1994; Vigano et al., 2001; Hanna et al., 2006; Hu et al., 2006 Hu et al., , 2008 Lash et al., 2006; Pitman et al., 2013) , or through dNK-EVT interaction via cell surface receptors (Wallace et al., 2012) . The observed mRNA expression may have been an overall effect of dNK-derived soluble factors, either from epigenetic modification, including DNA methylation, or transcriptional, post-transcriptional and translational regulation.
CLDN4 expression is frequently disrupted in various tumors (Michl et al., 2003; Agarwal et al., 2005; Boireau et al., 2007; Litkouhi et al., 2007; Kwon et al., 2011) , and is often inversely correlated with DNA methylation (Litkouhi et al., 2007; Kwon et al., 2011) . Elevated CLDN4 expression level has been shown to either decrease (Michl et al., 2003) Figure 6 Knockdown of CLDN4 and FUT4 expressions by siRNA in HTR8/SVneo reduces cell invasion. X-axis refers to the concentration of siRNA. *P , 0.001; **P , 0.01; ***P , 0.05. or increase (Agarwal et al., 2005; Litkouhi et al., 2007; Lee et al., 2008) tumor migration or invasion depending on cell type. MMP-2/MMP-9 level and activity appear to be regulated by CLDN4 (Oku et al., 2006; Lee et al., 2008) . CLDN4 expression is regulated by the MAPK signaling pathway (Carrozzino et al., 2009) . CLDN4 may modulate the activation of PI3K/AKt signaling pathway via altering Akt phosphorylation, cellular PIP3 content and PI3K activity (Lin et al., 2013) , which subsequently leads to activity changes of MMPs (Rychahou et al, 2004; Wang et al, 2004) . These results indicate that CLDN4 mediates the alteration of MMPs expression and activity potentially through MAPK and PI3K signaling pathways. We observed that knocking down CLDN4 in HTR8/SVneo reduced cell invasion, which was probably associated with reduced MMP-2 and MMP-9 activity ( Fig. 7a and b) . The lowered level of active MMP-2 and MMP-9 in CLDN4 knocked down HTR8/SVneo might reflect the reduced level of total MMP-2 and MMP-9.
FUT4 expression is increased in various tumor cells (Julien et al., 2011; Padro et al., 2011; Li et al., 2012) and regulated by promoter methylation (Li et al., 2012) . In breast cancer cells, FUT4 induced activation of phosphatidylinositol 3 kinase (PI3K)/AKT, and inactivation of glycogen synthase kinase 3 beta (GSK3b) and nuclear translocation of nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-lB), resulting in increased Snail and MMP-9 expression and greater cell mobility (Yang et al., 2013) . FUT4 also promotes cancer cell proliferation through activating MAPK and PI3K/AKT signaling pathways (Yang et al., 2010) . The alterations of PI3K/AKT and MAPK pathways are tightly linked to the activity changes of MMPs as described (Rychahou et al., 2004; Wang et al., 2004) . We showed that FUT4 knockdown in HTR8/SVneo cells by siRNA reduced cell invasion, which might be related to the reduction of MMP-9 activity although total MMP-9 expression was increased (Fig. 7d) , the same phenomenon we observed previously in EVT interacting with dNK in an explant culture model (Hu et al., 2006) . FUT4 knockdown in HTR8/SVneo might impact the activation process of MMP-9. The study in Age-related Macular Degeneration (AMD) patients found the reduction of fully active 84-kDa MMP-9 by observing the co-existence of a partially active 88-kDa transitional intermediate MMP-9, which implies the existence of problems with the Knockdown CLDN4 decreased active MMP-2 and total MMP-2 activities; (b) Knockdown CLDN4 decreased active and total MMP-9 activities; (c) Knockdown FUT4 did not significantly alter active MMP-2 and total MMP-2 activities; (d) Knockdown FUT4 decreased active MMP-9 expression while increased total MMP-9 activity. X-axis refers to the concentrations of siRNA. *P , 0.001; **P , 0.01; ***P , 0.05. MMP-9 cellular activation process (Hussain et al., 2011) . The phenomenon, however, needs to be studied in HTR8/SVneo cells. Our previous study demonstrated that dNK restricted EVT migration and invasion, which was associated with alterations of MMP-2 and MMP-9 expression and activity (Hu et al., 2006) . dNK modulated EVT mobility-related gene expression through methylation, with CLDN4 and FUT4 as examples, which might indirectly lead to changes in expression and activity of MMP-2 and/or MMP-9.
The present study has several limitations. This study was limited by the small sample size, and thus lacked the power for genome-wide correction for multiple comparisons. However, the power was strengthened by the use of genetically matched samples in our comparisons. A larger sample size would be required to draw more certain conclusions in terms of actual number of loci affected and degree of change. The follow-up studies for selected candidates, CLDN4 and FUT4, focused on an EVT cell line due to limited access to primary EVT. HTR8/SVneo is an immortalized EVT cell line that inherits the features of primary EVT (Graham et al., 1993) .
Despite the limitations, these data might suggest a regulatory effect of dNK on trophoblast, at least in part by altering gene expression through DNA methylation. CLDN4 and FUT4 are examples of genes that are regulated by dNK and associated with methylation alteration. In addition to changes in expression of CLDN4 and FUT4, the expression of downstream molecules MMP-2 and/or MMP-9 is further modulated, which ultimately leads to changes in the function of EVT such as EVT migration and invasion. Further study of other EVT mobility-related candidate genes would provide a broad spectrum of data regarding the regulation of trophoblast migration and invasion.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/.
